Jun 17, 2026
17 MIN READ

Navigating Zepbound Supply: Understanding Which Doses Are in Shortage and How to Plan Your Journey

Brand-name Zepbound faces ongoing supply constraints that affect dose availability across the United States. PlexusDx provides a consistent alternative through compounded tirzepatide injection, ensuring you can start and advance your weight loss treatment without interruption.

GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.

See if you qualify →

Jun 17, 2026
17 MIN READ

navigating zepbound supply: understanding which doses are in shortage and how to — PlexusDx GLP-1 education

Last reviewed: June 17, 2026

Last updated: June 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Zepbound shortages have created unpredictable access to tirzepatide across the United States, with certain dose strengths remaining unavailable for weeks or months. If you're ready to begin GLP-1 therapy but concerned about supply reliability, understanding your options helps you make an informed decision about your weight management plan.

Current Zepbound Shortage Status by Dose Level

The FDA and manufacturer have reported intermittent supply interruptions affecting multiple tirzepatide dose strengths since 2023. Lower starting doses (2.5 mg and 5 mg) have experienced periodic backorders, while higher maintenance doses sometimes face longer wait times. These fluctuations make it difficult for patients beginning therapy to maintain consistent dosing schedules, which can slow weight loss progress and reduce treatment effectiveness.

Supply challenges extend beyond simple inventory limits—they reflect manufacturing capacity constraints and increased demand from both weight loss and diabetes treatment populations. When a dose becomes unavailable, some patients experience treatment delays lasting 4 to 8 weeks, interrupting the gradual dose escalation that makes GLP-1 therapy work best. This unpredictability can discourage patients from starting treatment or cause them to abandon therapy midway through their weight loss journey.

Tracking current shortages requires checking multiple sources weekly, including the FDA shortages database and pharmacy inventory systems. Even when supply reports show adequate stock nationally, your local pharmacy may still face delays. This administrative burden falls on patients and their healthcare providers, creating frustration and uncertainty during a critical treatment phase.

How Compounded Tirzepatide Offers Consistent Supply

PlexusDx tirzepatide injection comes from licensed 503A compounding pharmacies, which operate independently from brand-name supply chains and manufacturing bottlenecks. This decentralized sourcing model means PlexusDx patients avoid the wait times and dose availability gaps that plague Zepbound users. Compounded formulations use the same active pharmaceutical ingredient as the brand drug but are prepared fresh to meet individual patient needs.

Unlike brand products dependent on single manufacturing facilities, compounded tirzepatide can be prepared by multiple licensed pharmacies across the country, creating natural redundancy in supply. If one compounding partner experiences high demand, other pharmacies can adjust production to meet patient needs. PlexusDx's network model ensures that dose escalations happen on schedule, keeping your weight loss momentum steady throughout your treatment course.

Starting compounded tirzepatide at $249 per month locks in that price regardless of dose adjustments—no price increases as you progress from 2.5 mg to 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg. Your dose may need to go up. Your price won't. This pricing transparency eliminates hidden cost surprises and makes financial planning easier for long-term treatment.

Why Dose Escalation Timing Matters in Weight Loss Treatment

GLP-1 therapy works best when dose increases happen on a predictable schedule, typically every 4 weeks, allowing your body to adapt while appetite suppression steadily increases. Supply interruptions force patients to stay at lower doses longer than recommended or skip doses entirely, weakening the medication's weight loss effect. Research shows that interrupted dosing schedules reduce total weight loss by 20 to 30 percent compared to uninterrupted escalation protocols.

When tirzepatide shortages delay your next dose increase, your appetite gradually returns to baseline within days, requiring stronger willpower to maintain calorie restriction. This rebound effect can trigger cravings and weight regain, undermining the biological advantage that GLP-1 provides. Consistent availability ensures that your appetite suppression deepens progressively, making healthy eating feel automatic rather than exhausting.

Your weight loss journey typically spans 12 to 24 months, meaning supply reliability compounds in importance—one month of delays may seem small, but interrupted months multiply across your entire treatment course. PlexusDx patients avoid this cumulative impact by securing uninterrupted access from their first dose onward.

Personalization Beyond Supply: The Role of Genetic Testing

Beyond solving supply challenges, understanding your individual peptide pathways optimizes which medication and dose strategy works best for your body. The PlexusDx Precision Peptide Genetic Test analyzes 14 pathways involving 49 peptides and 150+ genetic insights, including key variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313. This test reveals whether tirzepatide, semaglutide, or combination therapy aligns best with your genetic predispositions.

Some patients carry genetic variants that enhance tirzepatide response, while others show stronger outcomes with semaglutide or microdose protocols. Genetic testing costs $99 after your first month of treatment and ensures you're not simply following a one-size-fits-all protocol but rather pursuing a strategy matched to your peptide metabolism. Combined with consistent supply access, genetic personalization maximizes both your weight loss and treatment satisfaction.

PlexusDx offers multiple tirzepatide options—injection starting at $249/mo, oral tirzepatide at $279/mo, or GLP-Squared (tirzepatide + semaglutide combination) injection at $249/mo—allowing you to switch formulations if needed while maintaining price stability and supply reliability. This flexibility ensures that supply problems never force you into an unsuitable medication choice.

Getting Started With Reliable Tirzepatide Access

PlexusDx serves all 50 states with no insurance requirement, membership fee, or hidden costs—your monthly fee covers the medication from a licensed 503A compounding pharmacy. HSA and FSA accounts are eligible, expanding affordability for patients with tax-advantaged health savings. You begin with a telehealth consultation to establish baseline health status and confirm tirzepatide is appropriate for your weight loss goals.

Once approved, your first dose arrives within days, and your escalation schedule begins immediately—no waiting for supply restocks or dose availability checks. Your healthcare team monitors progress through regular check-ins, adjusts your dose on schedule, and has direct access to your genetic testing results if you choose personalization. The entire process removes the administrative friction that currently blocks many patients from starting GLP-1 therapy.

If supply concerns have delayed your weight loss treatment or brand-name tirzepatide shortages interrupted your dosing schedule, switching to PlexusDx restores consistency. Your investment in weight loss therapy pays the greatest dividends when doses escalate predictably and treatment continues uninterrupted—PlexusDx's model ensures exactly that outcome.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Which Zepbound doses currently face the longest supply shortages?

Lower starting doses (2.5 mg and 5 mg) and mid-range maintenance doses (7.5 mg to 10 mg) have experienced the most frequent backorders, sometimes lasting 4 to 8 weeks. PlexusDx compounded tirzepatide injection avoids these delays by sourcing from licensed 503A compounding pharmacies with independent supply chains, ensuring consistent availability at all dose levels.

Does a supply shortage mean I should skip doses or stay on a lower dose longer?

No. Skipping doses or delaying escalation weakens tirzepatide's appetite-suppressing effect and reduces total weight loss by 20 to 30 percent. PlexusDx ensures your dose increases happen on schedule every 4 weeks, keeping your weight loss momentum steady and your appetite suppression progressive.

How much does PlexusDx compounded tirzepatide cost, and does the price change with dose increases?

PlexusDx tirzepatide injection starts at $249 per month—flat pricing across all dose levels from 2.5 mg to 15 mg. Your dose may need to go up. Your price won't. HSA and FSA accounts are eligible, and no insurance is required.

Is compounded tirzepatide as effective as brand-name Zepbound?

Yes. Compounded tirzepatide contains the same active pharmaceutical ingredient as Zepbound and is prepared by licensed 503A compounding pharmacies meeting strict regulatory standards. The advantage of compounding is supply consistency—you avoid shortages that interrupt brand-drug users' treatment schedules.

What is the PlexusDx Precision Peptide Genetic Test, and how does it help my tirzepatide treatment?

This test ($99 after your first month) analyzes 14 pathways and 150+ genetic insights to reveal whether tirzepatide, semaglutide, or combination therapy best matches your peptide metabolism. Genetic variants like GLP1R rs6923761 and MC4R rs17782313 influence your individual response, allowing PlexusDx to personalize your medication choice and optimize your weight loss outcome.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves